| Selective NaV1. 1 activation rescues Dravet syndrome mice from seizures and premature death KL Richards, CJ Milligan, RJ Richardson, N Jancovski, M Grunnet, ... Proceedings of the National Academy of Sciences 115 (34), E8077-E8085, 2018 | 133 | 2018 |
| Therapeutic inhibition of acid-sensing ion channel 1a recovers heart function after ischemia–reperfusion injury MA Redd, SE Scheuer, NJ Saez, Y Yoshikawa, HS Chiu, L Gao, M Hicks, ... Circulation 144 (12), 947-960, 2021 | 48 | 2021 |
| Fifteen years of NaV1.7 channels as an analgesic target: Why has excellent in vitro pharmacology not translated into in vivo analgesic efficacy? DA Eagles, CY Chow, GF King British journal of pharmacology 179 (14), 3592-3611, 2022 | 44 | 2022 |
| Gating modifier toxins isolated from spider venom: Modulation of voltage-gated sodium channels and the role of lipid membranes AJ Agwa, S Peigneur, CY Chow, N Lawrence, DJ Craik, J Tytgat, GF King, ... Journal of Biological Chemistry 293 (23), 9041-9052, 2018 | 44 | 2018 |
| Three peptide modulators of the human voltage-gated sodium channel 1.7, an important analgesic target, from the venom of an Australian tarantula CY Chow, B Cristofori-Armstrong, EAB Undheim, GF King, LD Rash Toxins 7 (7), 2494-2513, 2015 | 33 | 2015 |
| A selective NaV1. 1 activator with potential for treatment of Dravet syndrome epilepsy CY Chow, YKY Chin, L Ma, EAB Undheim, V Herzig, GF King Biochemical pharmacology 181, 113991, 2020 | 26 | 2020 |
| Venom-derived modulators of epilepsy-related ion channels CY Chow, N Absalom, K Biggs, GF King, L Ma Biochemical Pharmacology 181, 114043, 2020 | 17 | 2020 |
| Venom Peptides with Dual Modulatory Activity on the Voltage-Gated Sodium Channel NaV1.1 Provide Novel Leads for Development of Antiepileptic Drugs CY Chow, YKY Chin, AA Walker, S Guo, LV Blomster, MJ Ward, V Herzig, ... ACS Pharmacology & Translational Science 3 (1), 119-134, 2019 | 16 | 2019 |
| Fluorescence labeling of a NaV1.7-targeted peptide for near-infrared nerve visualization J Gonzales, G Pirovano, CY Chow, PD de Souza Franca, LM Carter, ... EJNMMI research 10, 1-8, 2020 | 15 | 2020 |
| Novel venom-derived inhibitors of the human EAG channel, a putative antiepileptic drug target L Ma, YKY Chin, Z Dekan, V Herzig, CY Chow, J Heighway, SW Lam, ... Biochemical pharmacology 158, 60-72, 2018 | 15 | 2018 |
| Pharmacological Inhibition of the Voltage-Gated Sodium Channel NaV1.7 Alleviates Chronic Visceral Pain in a Rodent Model of Irritable Bowel Syndrome Y Jiang, J Castro, LV Blomster, AJ Agwa, J Maddern, G Schober, V Herzig, ... ACS Pharmacology & Translational Science 4 (4), 1362-1378, 2021 | 14 | 2021 |
| Development and Validation of Nerve-Targeted Bacteriochlorin Sensors J Hernández-Gil, CY Chow, H Chatras, PD de Souza França, ZV Samuels, ... Journal of the American Chemical Society 145 (26), 14276-14287, 2023 | 4 | 2023 |
| The voltage‐gated sodium channel NaV1.7 underlies endometriosis‐associated chronic pelvic pain J Castro, J Maddern, CY Chow, P Tran, I Vetter, GF King, SM Brierley Journal of Neurochemistry, 2023 | 2 | 2023 |
| Non-invasive diagnostic method to objectively measure olfaction and diagnose smell disorders by molecularly targeted fluorescent imaging agent D Adilbay, J Gonzales, M Zazhytska, PD de Souza Franca, S Roberts, ... bioRxiv, 2022 | 1 | 2022 |
| Cysteine-Rich α-Conotoxin SII Displays Novel Interactions at the Muscle Nicotinic Acetylcholine Receptor P Wilhelm, K Luna-Ramirez, YKY Chin, Z Dekan, N Abraham, HS Tae, ... ACS Chemical Neuroscience 13 (8), 1245-1250, 2022 | 1 | 2022 |
| NaV1. 7 targeted fluorescence imaging agents for nerve identification during intraoperative procedures J Gonzales, D Adilbay, PD de Souza Franca, R Artschwager, CY Chow, ... bioRxiv, 2024.04. 06.588368, 2024 | | 2024 |
Glenn F. KingProfessor, Institute for Molecular BioscienceVerified email at imb.uq.edu.au
